Shanghai INT Medical Instruments Co (HKSE:01501) EBIT : HK$195.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Shanghai INT Medical Instruments Co EBIT?

Shanghai INT Medical Instruments Co's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was HK$97.0 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$195.0 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Shanghai INT Medical Instruments Co's annualized ROC % for the quarter that ended in Dec. 2023 was 10.77%. Shanghai INT Medical Instruments Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 19.93%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Shanghai INT Medical Instruments Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 4.35%.

Shanghai INT Medical Instruments Co EBIT Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co EBIT Chart

Shanghai INT Medical Instruments Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

126.56

162.61

191.41

162.24

195.05

Shanghai INT Medical Instruments Co Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial								117.73	66.99	98.42	98.03	97.02

Competitive Comparison of Shanghai INT Medical Instruments Co's EBIT

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai INT Medical Instruments Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's EV-to-EBIT falls into.

Shanghai INT Medical Instruments Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$195.0 Mil.

Shanghai INT Medical Instruments Co (HKSE:01501) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Shanghai INT Medical Instruments Co's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	195.134 * ( 1 - 16.13% )	/	( (1482.737	+	1557.076)	/ 2 )
=	163.6588858	/	1519.9065
=	10.77 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2117.467	-	173.323	-	( 512.127	-	max(0, 335.08	-	796.487	+	512.127	))
=	1482.737

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	2219.962	-	217.215	-	( 475.133	-	max(0, 346.541	-	792.212	+	475.133	))
=	1557.076

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Shanghai INT Medical Instruments Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	194.036	/	( ( (945.912 + max(53.178, 0))	+	(893.171 + max(55.034, 0)) )	/	2 )
=	194.036	/	( ( 999.09	+	948.205 )	/	2 )
=	194.036	/	973.6475
=	19.93 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(65.337	+	168.666	+	49.186)	-	(173.323	+	0	+	56.688)
=	53.178

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(134.446	+	140.846	+	39.74)	-	(217.215	+	0	+	42.783)
=	55.034

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Shanghai INT Medical Instruments Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	195.045	/	4483.080
	=	4.35 %

Shanghai INT Medical Instruments Co EBIT Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.kdl-int.com

Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines